Nano‐G <sub>s</sub> Protein Peptidomimetics: Rational Design of Gα C‐Terminus‐Derived Peptides Mimicking Key Components of G <sub>s</sub> ‐β <sub>2</sub> AR Interactions

P Phuong Thu Tran (Department of Drug Design and Pharmacology University of Copenhagen Copenhagen Denmark) M Mia Danielsen (Department of Drug Design and Pharmacology University of Copenhagen Copenhagen Denmark) J Johanna K. S. Tiemann P Passainte Ibrahim (Universität Leipzig Medizinische Fakultät Leipzig Germany) S Søren G. F. Rasmussen (Department of Neuroscience University of Copenhagen Copenhagen Denmark) X Xavier Kubiak (Department of Neuroscience University of Copenhagen Copenhagen Denmark) H Hossein Batebi (Fachbereich Physik, Freie Universität Berlin, Arnimallee 14, Berlin 14195, Germany) C Charlène Gadais (Research Group of Organic Chemistry Departments of Chemistry and Bioengineering Sciences Vrije Universiteit Brussel Brussels Belgium) S Steven Ballet P Peter W. Hildebrand D Daniel Sejer Pedersen (CMC API Development, Chemical Development, Novo Nordisk A/S, Smørmosevej 17-19, Bagsværd 2880, Denmark) J Jesper Mosolff Mathiesen (Department of Drug Design and Pharmacology University of Copenhagen Copenhagen Denmark)

Abstract

ABSTRACT G protein‐coupled receptors (GPCRs) are involved in most human physiological processes and one of the largest families of approved drug‐targeted proteins. Heterotrimeric Gαβɣ proteins bind to the intracellular cavity of the activated receptor mainly through the C‐terminal α5 helix of the Gα subunit (GαCT). Modulation of GPCR activity through intracellular GPCR binding sites is emerging. Here we develop highly active Gα s CT‐derived peptidomimetics that stabilize the β 2 adrenergic receptor (β 2 AR) in an active‐like conformation when the helical conformation of Gα s CT is preserved by a covalent tether (“staple”). By rational design, integrating the information of two crystal structures showing different binding modes of Gα s CT with β 2 AR, an appropriate staple position was identified. The key interactions observed in the two distinct β 2 AR structures (β 2 AR‐G s (empty)) and β 2 AR‐T4L‐G s CT‐CC), namely Y391 and E392, were substituted with non‐canonical amino acids to improve activity. Optimization resulted in the identification of a potent peptidomimetic capable of stabilizing an active‐like receptor conformation, whilst blocking receptor‐mediated cAMP formation. Molecular dynamics simulations indicated a peptidomimetic binding mode that may represent another intermediate state preceding that of β 2 AR‐G s (empty). We envision this approach to be useful for further structural and functional exploration of other GPCRs or as a tool in drug discovery.

Article Details

Volume / Issue Vol. 65, Issue 24
Published June 08, 2026
ISSN 1433-7851
Publisher Wiley

Journal Info

Angewandte Chemie International Edition

Wiley

ISSN: 1433-7851 Physical Sciences

Authors (12)

P

Phuong Thu Tran

Department of Drug Design and Pharmacology University of Copenhagen Copenhagen Denmark

M

Mia Danielsen

Department of Drug Design and Pharmacology University of Copenhagen Copenhagen Denmark

J

Johanna K. S. Tiemann

P

Passainte Ibrahim

Universität Leipzig Medizinische Fakultät Leipzig Germany

S

Søren G. F. Rasmussen

Department of Neuroscience University of Copenhagen Copenhagen Denmark

X

Xavier Kubiak

Department of Neuroscience University of Copenhagen Copenhagen Denmark

H

Hossein Batebi

Fachbereich Physik, Freie Universität Berlin, Arnimallee 14, Berlin 14195, Germany

C

Charlène Gadais

Research Group of Organic Chemistry Departments of Chemistry and Bioengineering Sciences Vrije Universiteit Brussel Brussels Belgium

S

Steven Ballet

P

Peter W. Hildebrand

D

Daniel Sejer Pedersen

CMC API Development, Chemical Development, Novo Nordisk A/S, Smørmosevej 17-19, Bagsværd 2880, Denmark

J

Jesper Mosolff Mathiesen

Department of Drug Design and Pharmacology University of Copenhagen Copenhagen Denmark